The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing Epidemiology of the Disease
Abstract
We updated the incidence of primary hyperparathyroidism in Rochester, Minnesota. The lower rates previously noted persisted, whereas parathyroidectomies at our institution remained high. These data suggest an etiologic factor may be responsible for the peak incidence in the 1970s. Introduction: Automated serum calcium measurements were associated with a dramatic rise in primary hyperparathyroidism in the early 1970s, but a progressive decline in the incidence thereafter was unexpected and suggested a fundamental change in the epidemiology of the disease. Our objective was to evaluate trends in the incidence of primary hyperparathyroidism since 1992. Materials and Methods: In this population-based descriptive study, Rochester, MN, residents who met defined diagnostic criteria for primary hyperparathyroidism from January 1993 through December 2001 were identified through the medical record linkage system of the Rochester Epidemiology Project and the Mayo Clinic Laboratory Information System. Changes in incidence were evaluated by Poisson regression. Results: Altogether, 136 Rochester residents (94 women and 42 men) were newly identified with primary hyperparathyroidism in 1993–2001. Their mean age was 56 years, and 93% had definite disease. The overall age- and sex-adjusted (to 2000 U.S. whites) rate during this period was 21.6 per 100,000 person-years, which was less than the annual rate of 29.1 per 100,000 observed in 1983–1992 and 82.5 per 100,000 in July 1974–1982. Although community incidence declined, the number of parathyroidectomies performed at our institution increased during the same period. Serum calcium was deleted from the automated chemistry panel in June 1996, but most subjects remained asymptomatic at diagnosis (95%) with mild hypercalcemia. The majority of subjects were observed without parathyroid surgery (75%), and there was minimal impact on patient management from the 1990 NIH consensus conference on asymptomatic primary hyperparathyroidism. Conclusions: The lower incidence of primary hyperparathyroidism noted through 1992 has persisted in our community through 2001, whereas parathyroidectomies at our institution remained high. These data suggest that some underlying etiologic factor, in addition to the introduction of automated serum calcium testing, may have been responsible for the peak incidence in the 1970s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
WEBB, A. R., KLINE, L., & HOLICK, M. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-373 · Cited by 1,659
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443 · cited 3×
“(8) This information was supplemented by that available from the other providers of care to local residents, most notably Olmsted Medical Center.”
MethodResultInfluentialSelf-citationPrimary Hyperparathyroidism: Incidence, Morbidity, and Potential Economic Impact in a Community
Heath, H., Hodgson, S. F., & Kennedy, M. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001243020402 · Cited by 972
Gallagher, J. C., Riggs, B. L., Eisman, J., Hamstra, A., Arnaud, S. B., & Deluca, H. F. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109516 · Cited by 861
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 777
Bilezikian, J. P., Potts, J. T., Fuleihan, G. E.-H., Kleerekoper, M., Neer, R., Peacock, M., Rastad, J., Silverberg, S. J., Udelsman, R., & Wells, S. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021370 · Cited by 770
(1994) · PubMed · Cited by 419
PRIMARY HYPERPARATHYROIDISM: CHANGES IN THE PATTERN OF CLINICAL PRESENTATION
Mundy, G., Cove, D. H., & Fisken, R. A. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91783-3 · Cited by 379
Tannenbaum, C., Clark, J., Schwartzman, K., Wallenstein, S., Lapinski, R., Meier, D., & Luckey, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020275 · Cited by 314
Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results
Haas, J. S., Kaplan, C. P., Gerstenberger, E. P., & Kerlikowske, K. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00009 · Cited by 314
Epidemiology of primary hyperparathyroidism in Europe.
Adami, S., Marcocci, C., & Gatti, D. (2002) · PubMed · Cited by 308
Wermers, R. A., Khosla, S., Atkinson, E. J., Hodgson, S. F., O'Fallon, W. M., & Melton III, L. J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-6-199703150-00003 · Cited by 300
Self-citationThe effects of vitamin D insufficiency in patients with primary hyperparathyroidism
Silverberg, S. J., Shane, E., Dempster, D. W., & Bilezikian, J. P. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00294-6 · Cited by 254
Palumbo, P. J., Elveback, L. R., Chu, C.-P., Connolly, D. C., & Kurland, L. T. (1976) · Diabetes · doi:10.2337/diab.25.7.566 · Cited by 225
Calcium Intake Trends and Health Consequences from Childhood through Adulthood
Nicklas, T. A. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719317 · Cited by 173
Conjugated Estrogens in the Treatment of Postmenopausal Women with Hyperparathyroidism
MARCUS, R., MADVIG, P., CRIM, M., PONT, A., & KOSEK, J. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-633 · Cited by 166
The epidemiology of primary hyperparathyroidism in North America.
Melton, L. J. (2002) · PubMed · Cited by 122
Self-citationNational Trends in Osteoporosis Visits and Osteoporosis Treatment, 1988-2003
Stafford, R. S., Drieling, R. L., & Hersh, A. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1525 · Cited by 116
Dose-response relationships for radiation-induced hyperparathyroidism
Schneider, A. B., Gierlowski, T. C., Shore-Freedman, E., Stovall, M. A., Ron, E., & Lubin, J. H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.1.7829622 · Cited by 99
Nygren, P., Larsson, R. L., Johansson, H. E., Ljunghall, S., & Rastad, J. (1988) · Calcified Tissue International · doi:10.1007/bf02555137 · Cited by 89
Sex Steroids, Mice, and Men: When Androgens and Estrogens Get Very Close to Each Other
Bilezikian, J. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.563 · Cited by 59
Burke, J. P., HAY, I. D., Dignan, F. L., Goellner, J. R., Achenbach, S. J., Oberg, A. L., & Melton, L. J. (2005) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61529-2 · Cited by 51
Self-citationRenal leak of calcium in post‐menopausal osteoporosis
Nordin, B. E. C., Horowitz, M., Need, A. G., & Morris, H. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03782.x · Cited by 31
Cited by
Incidence and Prevalence of Primary Hyperparathyroidism in a Racially Mixed Population
Yeh, M. W., Ituarte, P. H. G., Zhou, H. C., Nishimoto, S., Amy Liu, I.-L., Harari, A., Haigh, P. I., & Adams, A. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4022 · Cited by 742
Walker, M. D., & Silverberg, S. J. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.104 · Cited by 566
Khan, A. A., Hanley, D. A., Rizzoli, R., Bollerslev, J., Young, J. E. M., Rejnmark, L., Thakker, R., D’Amour, P., Paul, T., Van Uum, S., et al. (2017) · Osteoporosis International · doi:10.1007/s00198-016-3716-2 · Cited by 544
Golden, S. H., Robinson, K. A., Saldanha, I., Anton, B., & Ladenson, P. W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2291 · Cited by 542
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Tebben, P. J., Singh, R. J., & Kumar, R. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1070 · Cited by 442
Metadata
- Authors
- Wermers, R. A., Khosla, S., Atkinson, E. J., Achenbach, S. J., Oberg, A. L., Grant, C. S., & Melton, L. J.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-01
- Volume
- 21
- Issue
- 1
- Pages
- 171-177
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1968923261
- Cited by
- 444
- References
- 26
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.